Cargando…

Cost Consequence Analysis of Belimumab versus Standard of Care for the Management of Systemic Lupus Erythematosus in Saudi Arabia: A Retrospective Cohort Study

Background: Belimumab use for the management of systemic lupus erythematosus (SLE) has been limited, in part due to its high acquisition cost relative to the standard of care (SoC) and the uncertainties about its cost-effectiveness. Therefore, the aim of this study was to compare the cost and effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsuwayegh, Aseel, Almaghlouth, Ibrahim A., Almasaoud, Majed Ali, Alzaid, Abdullah Sulaiman, Alsuhaibani, Adel Abdulaziz, Almana, Lyan Hassan, Alabdulkareem, Sara Mohammed, Abudahesh, Joud Abdullah, AlRuthia, Yazed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915237/
https://www.ncbi.nlm.nih.gov/pubmed/36767283
http://dx.doi.org/10.3390/ijerph20031917